Global pharmaceutical sales up 5 percent: IMS Health

Share this article:
Global pharmaceutical sales grew 5 percent in the 12 months to August in leading markets, IMS Health said this week.
Sales through retail pharmacies in 13 leading markets, which account for more than two-thirds of the world market, totaled $364 billion in the period.
The single largest drug class was cholesterol-lowering medicines, which sold $27.8 billion and showed a growth rate of 8.2 percent, a slight decrease, from the previous 12-month period.
Pfizer's Lipitor cholesterol pill remained the world's best-selling drug, with global sales of $11.2 billion, followed by Merck's Zocor, AstraZeneca's Nexium, Sanofi-Aventis and Bristol-Myers Squibb's Plavix, and GlaxoSmithKline's Advair/Seretide.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.